Physiotens Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Moxonidine

Indications/Uses

HTN.

Click to view Physiotens detailed prescribing information

Dosage/Direction for Use

Initially 0.2 mg daily. Max: 0.6 mg daily in 2 divided doses. Moderate renal impairment & patient undergoing hemodialysis Initially 0.2 mg daily, may be increased to 0.4 mg daily. Severe renal impairment Initially 0.2 mg daily, may be increased to 0.3 mg daily.

Click to view Physiotens detailed prescribing information

Overdosage

View Physiotens overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Sick sinus syndrome, bradycardia, 2nd- & 3rd-degree AV block, cardiac insufficiency.

Click to view Physiotens detailed prescribing information

Special Precautions

Not to be used in higher degree AV blocks. Patients w/ predisposition to developing AV block; severe CAD or unstable angina pectoris. Avoid abrupt discontinuation. Galactose intolerance, Lapp lactase deficiency or glucose-galactase malabsorption. Concomitant use w/ β-blockers. Renal impairment. Not to be used during pregnancy & lactation. Not recommended in childn & adolescents <18 yr.

Click to view Physiotens detailed prescribing information

Use In Pregnancy & Lactation

Click to view Physiotens detailed prescribing information

Adverse Reactions

Dry mouth. Insomnia; headache, dizziness, vertigo, somnolence; diarrhoea, nausea, vomiting, dyspepsia; rash, pruritus; back pain; asthenia.

Click to view Physiotens detailed prescribing information

Drug Interactions

Additive effect w/ other antihypertensive agents. Reduced effectiveness w/ TCAs. Potentiated sedative effects of TCAs, tranquilizers, alcohol, sedatives, hypnotics. Moderately augmented impaired performance in cognitive functions of lorazepam. Enhanced sedative effects of benzodiazepines.

Click to view Physiotens detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Physiotens detailed prescribing information

Storage

View Physiotens storage conditions for details to ensure optimal shelf-life.

Description

View Physiotens description for details of the chemical structure and excipients (inactive components).

Action

View Physiotens mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Antihypertensives

ATC Classification

C02AC05 - moxonidine ; Belongs to the class of imidazoline receptor agonists, centrally-acting antiadrenergic agents. Used in the treatment of hypertension.

Regulatory Classification

Presentation/Packing

Form

Physiotens FC tab 0.2 mg

Packing/Price

28's

Form

Physiotens FC tab 0.4 mg

Packing/Price

28's

Physiotens

moxonidine

Manufacturer:

Abbott

Distributor:

Zuellig Pharma